Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/10/2025

Tetanus Prophylaxis for Burn Injuries

Introduction to Tetanus Prophylaxis

  • The Centers for Disease Control and Prevention recommends that burn patients with unknown or outdated tetanus vaccination history receive both tetanus toxoid-containing vaccine (Tdap preferred) and tetanus immune globulin (TIG) 250 units IM at separate anatomic sites, followed by completion of the primary vaccination series 1, 2

Wound Classification and Management

  • Burns are classified as tetanus-prone wounds because they create nonintact skin that may be contaminated and can provide anaerobic conditions favorable for Clostridium tetani growth, determining a 5-year interval for booster administration in patients with known vaccination history 1, 2
  • Thorough wound cleaning and debridement is critical for tetanus prevention and should be performed immediately, removing all necrotic tissue and debris that might harbor C. tetani spores 1, 3

Vaccination Guidelines

  • The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend Tdap for adults ≥11 years, Td for adults >65 years, DTaP for children <7 years, and Td for children 7-10 years 1, 2
  • In mass-casualty or supply shortage situations, any tetanus vaccine formulation may be used regardless of age, as the tetanus toxoid content is adequate for all age groups 1

TIG Administration

  • The standard prophylactic dose of TIG is 250 units IM for both adults and children, administered at a separate site from tetanus toxoid injection 1, 3
  • Priority populations for TIG administration if supplies are limited include patients >60 years and immigrants from regions outside North America/Europe 1, 2, 3

Special Populations

  • Severely immunocompromised patients with contaminated wounds should receive TIG even with documented complete vaccination history 2, 3
  • Pregnant women requiring tetanus toxoid should receive Tdap regardless of prior Tdap history 2

Follow-Up Requirements

  • Patients receiving TIG should complete the 3-dose primary vaccination series, with the first dose given at injury, the second dose at ≥4 weeks, and the third dose at 6-12 months after the second dose 1, 2
  • After completing the primary series, booster doses every 10 years maintain adequate protection 2

Critical Clinical Pitfalls to Avoid

  • Do not confuse the 10-year routine booster interval with the 5-year interval for contaminated wounds, as this is the most common error in tetanus prophylaxis 2
  • Do not administer tetanus boosters more frequently than recommended, as this increases the risk of Arthus-type hypersensitivity reactions 2
  • Do not assume vaccination history, and treat patients with unknown histories as unvaccinated 1
  • Do not forget wound debridement, as proper surgical management is as important as immunization 1, 3
  • Do not withhold TIG from immunocompromised patients, even if they have documented complete vaccination 2, 3